Vascular	0	8	B-Gene_or_gene_product
endothelial	9	20	I-Gene_or_gene_product
growth	21	27	I-Gene_or_gene_product
factor	28	34	I-Gene_or_gene_product
(	35	36	O
VEGF	36	40	B-Gene_or_gene_product
)	40	41	O
in	42	44	O
seizures	45	53	O
:	53	54	O
a	55	56	O
double	57	63	O
-	63	64	O
edged	64	69	O
sword	70	75	O
.	75	76	O

Vascular	78	86	B-Gene_or_gene_product
endothelial	87	98	I-Gene_or_gene_product
growth	99	105	I-Gene_or_gene_product
factor	106	112	I-Gene_or_gene_product
(	113	114	O
VEGF	114	118	B-Gene_or_gene_product
)	118	119	O
is	120	122	O
a	123	124	O
vascular	125	133	O
growth	134	140	O
factor	141	147	O
which	148	153	O
induces	154	161	O
angiogenesis	162	174	O
(	175	176	O
the	176	179	O
development	180	191	O
of	192	194	O
new	195	198	O
blood	199	204	B-Multi-tissue_structure
vessels	205	212	I-Multi-tissue_structure
)	212	213	O
,	213	214	O
vascular	215	223	O
permeability	224	236	O
,	236	237	O
and	238	241	O
inflammation	242	254	O
.	254	255	O

In	256	258	O
brain	259	264	B-Organ
,	264	265	O
receptors	266	275	O
for	276	279	O
VEGF	280	284	B-Gene_or_gene_product
have	285	289	O
been	290	294	O
localized	295	304	O
to	305	307	O
vascular	308	316	B-Tissue
endothelium	317	328	I-Tissue
,	328	329	O
neurons	330	337	B-Cell
,	337	338	O
and	339	342	O
glia	343	347	B-Cell
.	347	348	O

VEGF	349	353	B-Gene_or_gene_product
is	354	356	O
upregulated	357	368	O
after	369	374	O
hypoxic	375	382	O
injury	383	389	O
to	390	392	O
the	393	396	O
brain	397	402	B-Organ
,	402	403	O
which	404	409	O
can	410	413	O
occur	414	419	O
during	420	426	O
cerebral	427	435	O
ischemia	436	444	O
or	445	447	O
high	448	452	O
-	452	453	O
altitude	453	461	O
edema	462	467	B-Pathological_formation
,	467	468	O
and	469	472	O
has	473	476	O
been	477	481	O
implicated	482	492	O
in	493	495	O
the	496	499	O
blood	500	505	B-Multi-tissue_structure
-	505	506	I-Multi-tissue_structure
brain	506	511	I-Multi-tissue_structure
barrier	512	519	I-Multi-tissue_structure
breakdown	520	529	O
associated	530	540	O
with	541	545	O
these	546	551	O
conditions	552	562	O
.	562	563	O

Given	564	569	O
its	570	573	O
recently	574	582	O
-	582	583	O
described	583	592	O
role	593	597	O
as	598	600	O
an	601	603	O
inflammatory	604	616	O
mediator	617	625	O
,	625	626	O
VEGF	627	631	B-Gene_or_gene_product
could	632	637	O
also	638	642	O
contribute	643	653	O
to	654	656	O
the	657	660	O
inflammatory	661	673	O
responses	674	683	O
observed	684	692	O
in	693	695	O
cerebral	696	704	O
ischemia	705	713	O
.	713	714	O

After	715	720	O
seizures	721	729	O
,	729	730	O
blood	731	736	B-Multi-tissue_structure
-	736	737	I-Multi-tissue_structure
brain	737	742	I-Multi-tissue_structure
barrier	743	750	I-Multi-tissue_structure
breakdown	751	760	O
and	761	764	O
inflammation	765	777	O
is	778	780	O
also	781	785	O
observed	786	794	O
in	795	797	O
brain	798	803	B-Organ
,	803	804	O
albeit	805	811	O
on	812	814	O
a	815	816	O
lower	817	822	O
scale	823	828	O
than	829	833	O
that	834	838	O
observed	839	847	O
after	848	853	O
stroke	854	860	O
.	860	861	O

Recent	862	868	O
evidence	869	877	O
has	878	881	O
suggested	882	891	O
a	892	893	O
role	894	898	O
for	899	902	O
inflammation	903	915	O
in	916	918	O
seizure	919	926	O
disorders	927	936	O
.	936	937	O

We	938	940	O
have	941	945	O
described	946	955	O
striking	956	964	O
increases	965	974	O
in	975	977	O
VEGF	978	982	B-Gene_or_gene_product
protein	983	990	O
in	991	993	O
both	994	998	O
neurons	999	1006	B-Cell
and	1007	1010	O
glia	1011	1015	B-Cell
after	1016	1021	O
pilocarpine	1022	1033	B-Drug_or_compound
-	1033	1034	O
induced	1034	1041	O
status	1042	1048	O
epilepticus	1049	1060	O
in	1061	1063	O
the	1064	1067	O
brain	1068	1073	B-Organ
.	1073	1074	O

Increases	1075	1084	O
in	1085	1087	O
VEGF	1088	1092	B-Gene_or_gene_product
could	1093	1098	O
contribute	1099	1109	O
to	1110	1112	O
the	1113	1116	O
blood	1117	1122	B-Multi-tissue_structure
-	1122	1123	I-Multi-tissue_structure
brain	1123	1128	I-Multi-tissue_structure
barrier	1129	1136	I-Multi-tissue_structure
breakdown	1137	1146	O
and	1147	1150	O
inflammation	1151	1163	O
observed	1164	1172	O
after	1173	1178	O
seizures	1179	1187	O
.	1187	1188	O

However	1189	1196	O
,	1196	1197	O
VEGF	1198	1202	B-Gene_or_gene_product
has	1203	1206	O
also	1207	1211	O
been	1212	1216	O
shown	1217	1222	O
to	1223	1225	O
be	1226	1228	O
neuroprotective	1229	1244	O
across	1245	1251	O
several	1252	1259	O
experimental	1260	1272	O
paradigms	1273	1282	O
,	1282	1283	O
and	1284	1287	O
hence	1288	1293	O
could	1294	1299	O
potentially	1300	1311	O
protect	1312	1319	O
vulnerable	1320	1330	O
cells	1331	1336	B-Cell
from	1337	1341	O
damage	1342	1348	O
associated	1349	1359	O
with	1360	1364	O
seizures	1365	1373	O
.	1373	1374	O

Therefore	1375	1384	O
,	1384	1385	O
the	1386	1389	O
role	1390	1394	O
of	1395	1397	O
VEGF	1398	1402	B-Gene_or_gene_product
after	1403	1408	O
seizures	1409	1417	O
could	1418	1423	O
be	1424	1426	O
either	1427	1433	O
protective	1434	1444	O
or	1445	1447	O
destructive	1448	1459	O
.	1459	1460	O

Although	1461	1469	O
only	1470	1474	O
further	1475	1482	O
research	1483	1491	O
will	1492	1496	O
determine	1497	1506	O
the	1507	1510	O
exact	1511	1516	O
nature	1517	1523	O
of	1524	1526	O
VEGF	1527	1531	B-Gene_or_gene_product
'	1531	1532	O
s	1532	1533	O
role	1534	1538	O
after	1539	1544	O
seizures	1545	1553	O
,	1553	1554	O
preliminary	1555	1566	O
data	1567	1571	O
indicate	1572	1580	O
that	1581	1585	O
VEGF	1586	1590	B-Gene_or_gene_product
plays	1591	1596	O
a	1597	1598	O
protective	1599	1609	O
role	1610	1614	O
after	1615	1620	O
seizures	1621	1629	O
.	1629	1630	O

